
Meet The Professor: Optimizing the Management of Multiple Myeloma — Part 4 of a 4-Part Series
Hematologic Oncology Update
00:00
Is There a Role to Combine Lenalidomide With Darratumumab?
Darratumab is a very reasonable treatment approach in this patient, says Dr. Warren Brenner. If they finish their stipulated cycles of the Darratumab, your question on maintenance again goes to what their risk factors are from a genetic standpoint. Revlimid maintenance with Darrumab for up to two years at least, and Bortesumab every other week as maintenance.
Transcript
Play full episode